Peter S. Klein
7Patents
3h-index
8Co-inventors
50Inventor score
Filing activity: Nov 2, 1992 → Mar 30, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6441053B1 | Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same | Human Necessities | 23 | Expired |
| US6210708A | Cationic virosomes as transfer system for genetic material | Chemistry; Metallurgy | 8 | Expired |
| US6040167A | Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems | Human Necessities | 3 | Expired |
| US9050315B2 | In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs | Chemistry; Metallurgy | 1 | Active |
| US7378111B2 | Regulation of GSK-3α activity for the treatment or prevention of Alzheimer's disease | Human Necessities | 0 | Expired |
| US6316236A | Lysozyme dimer | Chemistry; Metallurgy | 0 | Expired |
| US9452187B2 | In vivo and ex vivo expansion of hematopoietic stem cells with a targeted combination of clinically tested, FDA approved drugs | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.